Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
September 13, 2022 12:32 PM 2 min read

Oracle's Cloud Business Sustains Momentum On Heels Of Mixed Quarter Results, Cerner Deal

by Priya Nigam Benzinga Staff Writer
Follow

ArticleFeaturedTickersList12345!!!

Shares of Oracle Corporation (NYSE:ORCL) rose during Monday’s after-hours session, despite the Austin, Texas-based company posting earnings short of expectations.

Investors bought Oracle shares after the database software giant reported quarterly upbeat revenues with a healthy contribution from the recently acquired medical records firm Cerner.

See Also: Oracle Buys Cerner At Premium

Morgan Stanley

Analyst Keith Weiss reiterated an Equal-Weight rating and a price target of $90.

“Even looking through the inorganic contributions from Cerner, the Cloud businesses at Oracle look to be well sustaining momentum with total Cloud revenues (excluding Cerner) up 29% YoY in constant currency (cc), back office applications now exceeding a $5.8 billion revenue run rate growing at 33% YoY cc, and the Oracle Cloud Infrastructure (OCI) reaching a $3.2 billion run rate with 70% growth,” Weiss wrote.

“Looking forward, the spike in capex spending to $1.7 billion in the quarter (of which the vast majority is supporting OCI) likely reflects Cloud contracts in hand or with clear line of sight, as Oracle management does not take the philosophy of "build it and they will come", but much prefers to build to suit,” he added.

Piper Sandler

Analyst Brent Bracelin reaffirmed an Underweight rating and a price target of $70.

“The combination of Cerner integration expenses and rising cloud costs have pressured the operating margin to slip below 40% for the first time in six years,” Bracelin said. “While the Oracle Cloud business continues to hold promise, the blended organic growth rate of 45% suggests it is growing roughly in-line with our CloudTracker growth trends on aggregate."

Check Out Our Other Analyst Stock Ratings

Credit Suisse

Analyst Phil Winslow maintained an Outperform rating and a price target of $115.

Oracle’s quarterly results were solid and the “standout this quarter was infrastructure cloud services,” Winslow said.

“Oracle’s strong FQ1 results and FQ2 and FY2223 guidance commentary reinforce our view that Oracle is well positioned to emerge as the #3/#4 vendor in the PaaS/IaaS market and the #2 vendor in the SaaS market – enabling the company to continue to reaccelerate revenue growth into the double digits,” he added.

ORCL Price Action: Shares of Oracle had risen by 0.75% to $77.68 at the time of publication Tuesday.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorEarningsNewsReiterationAnalyst RatingsMoversTrading IdeasBrent BracelinCredit SuisseKeith WeissMorgan StanleyPiper Sandler
ORCL Logo
ORCLOracle Corp
$143.400.40%
Overview
ORCL Logo
ORCLOracle Corp
$143.400.40%
Overview
Comments
Loading...